F5 vs Everpure
FFIV and P side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FFIV and P compare
Everpure is the larger company, worth 2.0 times as much as F5 ($35.5B against $18.1B).
On earnings, F5 is cheaper: it trades at 25.5× trailing earnings, against 146× for Everpure.
Everpure grew revenue faster over the last twelve months (27.2% versus 9.4% for F5).
F5 keeps more of each dollar of sales as profit, with a net margin of 22.0% compared with 5.9% at Everpure.
Everpure scores higher on the StockData Score (16 against 14 for F5), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FFIV | P |
|---|---|---|
| Size and price | ||
| Market cap | $18.1B | $35.5B |
| Share price | $320.01 | $106.50 |
| Change, 1 year | 32.9% | 15.2% |
| Change, 5 years | 38.0% | 285% |
| Beta (5Y) | 0.97 | 1.62 |
| Employees | 6,578 | 6,400 |
| StockData Score | ||
| Total score | 14 | 16 (better) |
| Valuation score | 2 | 2 |
| Growth score | 3 | 4 (better) |
| Performance score | 3 | 4 (better) |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 25.5× (better) | 146× |
| P/S | 5.5× (better) | 8.3× |
| P/B | – | 23.0× |
| EV/EBITDA | 18.2× (better) | 92.9× |
| P/FCF | 18.7× (better) | 277× |
| PEG | 0.83 (better) | 4.33 |
| FCF yield | 5.4% (better) | 0.36% |
| Fair value | $297.72 | $31.71 |
| Margin of safety | −7.5% (better) | −236% |
| Growth | ||
| Revenue growth (TTM) | 9.4% | 27.2% (better) |
| Revenue growth, 5Y average | 5.6% | 16.8% (better) |
| Net income growth (TTM) | 8.9% | 82.0% (better) |
| EPS growth (TTM) | 10.7% | 78.0% (better) |
| EPS growth, 5Y average | 18.7% | – |
| Profitability | ||
| Gross margin | 81.9% (better) | 69.7% |
| Operating margin | 24.5% (better) | 5.3% |
| Net margin | 22.0% (better) | 5.9% |
| FCF margin | 29.3% (better) | 3.0% |
| Return on equity | – | 17.7% |
| Return on invested capital | – | 25.6% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | – | 214× |
| Current ratio | 1.66 (better) | 1.51 |
| Altman Z-score | 5.52 | 6.71 (better) |
| Piotroski F-score | 9 (better) | 7 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.94% |
| Shareholder yield | 0.00% | 0.94% (better) |
| Ownership | ||
| Held by institutions | 96.6% | 83.0% |
| Held by insiders | 0.64% | 3.5% |
| Insider net buying, 12 months | −$31.9M (better) | −$346M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 2.2% | 2.6% |
Go deeper
- FFIV stock overview
- FFIV income statement
- FFIV valuation and score
- P stock overview
- P income statement
- P valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.